Cite

    Fedirko, V., McKeown‐Eyssen, G., Serhan, C. N., Barry, E. L., Sandler, R. S., Figueiredo, J. C., Ahnen, D. J., Bresalier, R. S., Robertson, D. J., Anderson, C. W., & Baron, J. A. (2017). plasma lipoxin A4 and resolvin D1 are not associated with reduced adenoma risk in a randomized trial of aspirin to prevent colon adenomas. Molecular carcinogenesis, 56(8), 1977–1983. http://access.bl.uk/ark:/81055/vdc_100047417631.0x000032